DISCOUNT OPTIONSSCHEIN - AMGEN | Real-time Bid/Ask 15:10:28 13/05/2024 BST | ||
| 3.08 EUR / 3.25 EUR | +1.77% |
|
| Current month | +73.74% | ||
| 1 month | +57.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/24 | 3.06 | -1.61% | 0 |
| 10/05/24 | 3.11 | -4.60% | 0 |
| 09/05/24 | 3.26 | +16.01% | 0 |
| 08/05/24 | 2.81 | +8.91% | 0 |
| 07/05/24 | 2.58 | +3.61% | 0 |
Delayed Quote Börse Stuttgart
Last update May 13, 2024 at 09:56 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME85YX |
| ISIN | DE000ME85YX5 |
| Date issued | 05/02/2024 |
| Strike | 400 $ |
| Maturity | 20/12/2024 (221 Days) |
| Parity | 1 : 1 |
| Emission price | 2.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.81 € |
|---|---|
| Lowest since issue | 1.47 € |
| Spread | 0.14 € |
| Spread % | 4.42% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
